Octapharma USA & BioMatrix support research focused on COVID-19 & myocardial dysfunction
PARAMUS, N.J. (May 28, 2020) – Octapharma USA and BioMatrix Specialty Pharmacy are supporting a new investigator-initiated research study led by Kelly McCants, M.D., Medical Director of the Norton Heart & Vascular Institute in Louisville, Ky., focused on treating patients with the coronavirus (COVID-19) and presenting with COVID-19-associated myocardial dysfunction. Octapharma USA is donating Octagam…